Literature DB >> 33663441

Clonazepam-induced lichenoid drug eruption: a case report.

Hee Won Yang1, Jong Bin Bae2,3, Jung-Im Na4, Ki Woong Kim1,5,6.   

Abstract

BACKGROUND: Lichenoid drug eruption is rare and can mimic idiopathic lichen planus and other dermatoses. Clonazepam, a commonly used drug for the treatment of anxiety-related disorders and seizures, is known to be an unlikely cause of cutaneous adverse effects. Only one case report of LDE due to clonazepam has been reported. CASE
PRESENTATION: A 81-year-old male patient with Alzheimer's disease developed a lichenoid eruption after taking clonazepam. He developed a violaceous scaly patch on his lower extremities, from both buttocks to the feet. The cutaneous eruption resolved 2 months after cessation of clonazepam and with initiation of corticosteroid therapy.
CONCLUSION: A skin eruption that develops after clonazepam administration can be a lichenoid drug eruption, which is less likely to resolve spontaneously and requires discontinuation of clonazepam administration.

Entities:  

Keywords:  Clonazepam; Cutaneous; Drug eruption; Lichenoid

Year:  2021        PMID: 33663441      PMCID: PMC7934486          DOI: 10.1186/s12888-021-03132-2

Source DB:  PubMed          Journal:  BMC Psychiatry        ISSN: 1471-244X            Impact factor:   3.630


  20 in total

Review 1.  Implications of cytochrome P450 interactions when prescribing medication for hypertension.

Authors:  David A Flockhart; Jose E Tanus-Santos
Journal:  Arch Intern Med       Date:  2002-02-25

2.  Suspected clonazepam-induced bullous dermatosis in a patient with respiratory failure.

Authors:  Ming-Chia Lee; Chiu-Ping Su; Chun-Hua Wang; Chou-Chin Lan; Ta-Wei Wu
Journal:  J Clin Pharmacol       Date:  2011-12-12       Impact factor: 3.126

3.  Localized exfoliating rash with paresthesia possibly due to clonazepam.

Authors:  Ravindra N Munoli; Samir K Praharaj; Shripathy M Bhatt
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-08       Impact factor: 2.576

4.  Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability.

Authors:  P Scheltens; L J Launer; F Barkhof; H C Weinstein; W A van Gool
Journal:  J Neurol       Date:  1995-09       Impact factor: 4.849

5.  Enalapril-induced lichen planus-like eruption.

Authors:  S V Roten; C Mainetti; R Donath; J H Saurat
Journal:  J Am Acad Dermatol       Date:  1995-02       Impact factor: 11.527

Review 6.  Lichenoid drug eruptions.

Authors:  S Halevy; A Shai
Journal:  J Am Acad Dermatol       Date:  1993-08       Impact factor: 11.527

7.  Photosensitive lichenoid eruption due to enalapril.

Authors:  A J Kanwar; S Dhar; S Ghosh
Journal:  Dermatology       Date:  1993       Impact factor: 5.366

8.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

9.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

Review 10.  Adverse cutaneous drug eruptions: current understanding.

Authors:  W Hoetzenecker; M Nägeli; E T Mehra; A N Jensen; I Saulite; P Schmid-Grendelmeier; E Guenova; A Cozzio; L E French
Journal:  Semin Immunopathol       Date:  2015-11-09       Impact factor: 11.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.